Vernal keratoconjunctivitis (VKC) is an ocular disorder characterized by severe inflammation affecting both the cornea and ...

Its success is heavily reliant on products like VTAMA, currently approved for psoriasis and under investigation for atopic ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

Dupixent has been approved for CSU in Japan and the United Arab Emirates (UAE) and is also under regulatory review ... including certain patients with atopic dermatitis, asthma, chronic ...

The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...

Expert Rev Clin Immunol. 2013;9(3):211-216. Atopic dermatitis is a chronic inflammatory skin disease that commonly begins in early infancy, runs a course of exacerbations and remissions and is ...

Corvus Pharmaceuticals’ stock surged from under $2 to $10. Learn why CRVS stock is gaining attention with promising pipeline ...